LINACS
LINACS Home
OligoCare
Group

Anti-idiotype vaccine mAb

The data below refer to patients treated with Anti-idiotype vaccine mAb as the sole drug class, excluding any concurrent use of drugs from other groups.
Individual Drugs

Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.

Racotumomab
No data